Editor(s):

(1) Dr. Takashi Ikeno, National Center of Neurology and Psychiatry, Japan.

Reviewers:

(1) Mohamed El-Helaly, Mansoura University, Egypt.

(2) Amal Mohamed Kamal El Safty, Cairo University, Egypt.

(3) Uzoekwe Helen E, Nnamdi Azikiwe University, Nigeria.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.33/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Mohamed El-Helaly, Egypt) | File 1 | File 2

Stage 2 | Peer review report_2 (Amal Mohamed Kamal El Safty, Egypt) | File 1 | File 2

Stage 2 | Peer review report_3 (Uzoekwe Helen E., Nigeria) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Jongwha Chang, The University of Texas at Austin College of Pharmacy, USA.

Reviewers:

(1) Majid Mohammed Mahmood, Mustansiriyah University, Iraq.

(2) Dennis Amaechi, Veritas university, Nigeria.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.55/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Majid Mohammed Mahmood, Iraq) | File 1 | NA

Stage 2 | Peer review report_2 (Dennis Amaechi, Nigeria) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Asmaa Fathi Moustafa Hamouda, Jazan University, Saudi Arabia.

Reviewers:

(1) Asma Ghatea Oraibi, Al-Nahrain University, Iraq.

(2) Ritesh Kumar Tiwari, Shri Ram Murti Smarak College of Engineering, Technology & Research Bareilly, India.

Additional Reviewers:

(1) Sadí  Cossy  Isasi, Universidad Nacional de Córdoba, Argentina.

(2) Shabnam Ahmadi , Tarbiat Modares University, Iran.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Asma Ghatea Oraibi, Iraq) | File 1 | NA

Stage 2 | Peer review report_2 (Ritesh Kumar Tiwari, India) | File 1 | File 2

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Stage 3 | Revised_MS_v2_and_Feedback_v2 | File 1 | NA

Editor(s):

(1) Dr. Asmaa Fathi Moustafa Hamouda, Assistant Professor, Jazan University, Saudi Arabia.

(2) Dr. Rafik Karaman, Professor, Al-Quds University, Jerusalem, Palestine.

Reviewers:

(1) Zeshan Haider Raza, University of Veterinary and Animal Sciences, Pakistan.

(2) Huynh Tan Hoi, FPT University, Vietnam.

(3) Merita Kucuku, University Aleksander Xhuvani, Albania.

(4) Dhruba Sankar Goswami, Gitanjali College of Pharmacy, India.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.8/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Zeshan Haider Raza, Pakistan) | File 1 | NA

Stage 2 | Peer review report_2 (Huynh Tan Hoi, Vietnam) | File 1 | NA

Stage 2 | Peer review report_3 (Merita Kucuku, Albania) | File 1 | File 2

Stage 2 | Peer review report_4 (Dhruba Sankar Goswami, India) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Stage 3 | Revised_MS_v2_and_Feedback_v2 | File 1 | NA

Stage 3 | Comment_Editor_2_v1 | File 1 | NA

Editor(s):

(1) Dr. Rafik Karaman, Al-Quds University,Palestine.

Reviewers:

(1) Peter Awoyesuku, Rivers State University, Nigeria.

(2) Manjusha Jindal, Goa Medical College, India.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.5/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Peter Awoyesuku, Nigeria) | File 1 | File 2

Stage 2 | Peer review report_2 (Manjusha Jindal, India) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Juan Carlos Troiano, University of Buenos Aires, Argentina.

Reviewers:

(1)  Shinu Kuriakose, New York Institute of Technology, USA.

(2) Christian Molima Eboma, Université Catholique de Bukavu Campus De Bugabo, Congo.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7.5/10

Average Peer review marks at publication stage: 8.5/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Shinu Kuriakose, USA) | File 1 | NA

Stage 2 | Peer review report_2 (Christian Molima Eboma, Congo) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Paola Angelini, University of Perugia, Italy.

Reviewers:

(1) Mohammad Abdul Baseer, Riyadh Elm University, Saudi Arabia.

(2) Mohammad M Al Mailem, Jazan University, Saudi Arabia.

Additional Reviewers:

(1) Bojan Obradovic, Bosnia & Herzegovina.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 9/10

Average Peer review marks at publication stage: 9.5/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Mohammad Abdul Baseer, Saudi Arabia) | File 1 | File 2

Stage 2 | Peer review report_2 (Mohammad M Al Mailem, Saudi Arabia) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Rafik Karaman, Professor, College of Pharmacy, Al-Quds University, Palestine.

Reviewers:

(1) Muhammad Shuaib, Yunnan University, China.

(2) Bhavya B.M, Central Ayurveda Research Institute, India.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7.5/10

Average Peer review marks at publication stage: 8.5/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Muhammad Shuaib, China) | File 1 | NA

Stage 2 | Peer review report_2 (Bhavya B.M, India) | File 1 | File 2

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Paola Angelini, University of Perugia,  Perugia,  Italy.

Reviewers:

(1) Neeraj Gupta, J L N Medical College, India.

(2) Ogbonna Collins Nwabuko, University of Calabar, Nigeria.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 6.5/10

Average Peer review marks at publication stage: 8.25/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Ogbonna Collins Nwabuko, Nigeria) | File 1 | File 2

Stage 2 | Peer review report_2 (Neeraj Gupta India) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Jongwha Chang, University of Texas, College of Pharmacy, USA.

Reviewers:

(1) Sathyamurthy P, Sri Ramachandra University, India.

(2) Shiddanagouda K B, Rajiv Gandhi University of Health Sciences, India.

Additional Reviewers:

(1) Navneet Sonawane, Matoshree Clinic, India.

(2) P KPrajapati, Dehli University, All India Institute of Ayurveda, India.

(3) Santosh Gulabrao Chavhan, D Y Patil Deemed to be University, India.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 6.5/10

Average Peer review marks at publication stage: 8.5/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Sathyamurthy P, India) | File 1 | NA

Stage 2 | Peer review report_2 (Shiddanagouda K B, India) | File 1 | File 2

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA